Insider trading

Period: 120 months Stock: NBIX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

545 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

545 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

545 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

545 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
545 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
545 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

545 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Aug 2022
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$2.28M 21,533 at 105.95
53.3%
Sold half or more
5 Aug 2022
Cooke Julie Chief Human Resources Officer
Sold, plan not stated
$181.60K 1,816 at 100.00
10.7%
27 Jun 2022
Cooke Julie Chief Human Resources Officer
Sold, plan not stated
$75.40K 754 at 100.00
4.3%
9 May 2022
POPS RICHARD F Director
Sold, plan not stated 2×
$1.14M 15,000 at 76.30
33.7%
25 Apr 2022
LYONS GARY A Director
Sold, plan not stated
$1.39M 15,000 at 92.76
6.7%
1 Apr 2022
Sold, plan not stated
$1.02M 10,728 at 94.93
24.0%
22 Mar 2022
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$803.66K 8,455 at 95.05
22.3%
18 Mar 2022
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$28.50K 300 at 95.00
0.8%
8 Feb 2022
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$180.77K 2,274 at 79.49
0.5%
8 Feb 2022
Gano Kyle Chief Business Development Off
Sold, plan not stated
$78.08K 980 at 79.67
0.9%
8 Feb 2022
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated
$78.07K 980 at 79.67
4.6%
8 Feb 2022
ABERNETHY MATT Chief Financial Officer
Sold, plan not stated
$78.06K 980 at 79.65
4.6%
8 Feb 2022
ROBERTS EIRY Chief Medical Officer
Sold, plan not stated
$77.93K 980 at 79.52
3.8%
8 Feb 2022
Lippoldt Darin Chief Legal Officer
Sold, plan not stated
$72.43K 911 at 79.51
2.3%
8 Feb 2022
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$55.75K 701 at 79.53
3.6%
8 Feb 2022
Boyer David W. Chief Corp. Affairs Officer
Sold, plan not stated
$55.74K 700 at 79.62
19.3%
8 Feb 2022
Cooke Julie Chief Human Resources Officer
Sold, plan not stated
$55.69K 700 at 79.56
3.9%
7 Feb 2022
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated 3×
$703.91K 8,710 at 80.82
1.9%
7 Feb 2022
Gano Kyle Chief Business Development Off
Sold, plan not stated 4×
$476.55K 5,900 at 80.77
5.3%
7 Feb 2022
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated 3×
$332.75K 4,119 at 80.78
20.0%
7 Feb 2022
ABERNETHY MATT Chief Financial Officer
Sold, plan not stated 2×
$267.43K 3,310 at 80.79
15.4%
7 Feb 2022
Lippoldt Darin Chief Legal Officer
Sold, plan not stated 3×
$255.73K 3,168 at 80.72
8.3%
7 Feb 2022
ROBERTS EIRY Chief Medical Officer
Sold, plan not stated 2×
$221.66K 2,744 at 80.78
10.8%
7 Feb 2022
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated 3×
$216.42K 2,681 at 80.72
14.0%
7 Feb 2022
Cooke Julie Chief Human Resources Officer
Sold, plan not stated 3×
$174.04K 2,158 at 80.65
12.3%
7 Feb 2022
Boyer David W. Chief Corp. Affairs Officer
Sold, plan not stated
$19.46K 240 at 81.07
9.5%
24 Jan 2022
Sold, plan not stated
$1.12M 15,000 at 74.43
37.4%
10 Jan 2022
ROBERTS EIRY Chief Medical Officer
Sold, plan not stated
$196.09K 2,632 at 74.50
11.0%
5 Jan 2022
Gano Kyle Chief Business Development Off
Sold, plan not stated
$2.42M 28,266 at 85.50
21.2%
1 Dec 2021
ABERNETHY MATT Chief Financial Officer
Sold, plan not stated
$135.85K 1,645 at 82.59
9.1%
7 Oct 2021
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated 2×
$838.51K 8,000 at 104.81
8.9%
7 Oct 2021
LYONS GARY A Director
Sold, plan not stated
$525.29K 5,000 at 105.06
2.3%
4 Oct 2021
Cooke Julie Chief Human Resources Officer
Sold, plan not stated
$100.41K 987 at 101.73
6.2%
16 Aug 2021
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated
$504.39K 5,628 at 89.62
26.5%
27 Jul 2021
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated
$1.57M 16,709 at 93.80
51.4%
Sold half or more
10 Jun 2021
LYONS GARY A Director
Sold, plan not stated
$1.00M 10,000 at 100.27
4.5%
10 Feb 2021
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated 2×
$203.93K 1,700 at 119.96
5.0%
9 Feb 2021
Lippoldt Darin Chief Legal Officer
Sold, plan not stated 3×
$4.20M 36,194 at 116.17
51.3%
Sold half or more
8 Feb 2021
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated 3×
$1.22M 10,466 at 116.75
2.3%
8 Feb 2021
BENEVICH ERIC Chief Commercial Officer
Sold, plan not stated 3×
$498.84K 4,270 at 116.82
19.2%
8 Feb 2021
Bozigian Haig P. Chief Development Officer
Sold, plan not stated 3×
$448.75K 3,842 at 116.80
2.4%
8 Feb 2021
Gano Kyle Chief Business Development Off
Sold, plan not stated 3×
$431.52K 3,693 at 116.85
3.5%
8 Feb 2021
Lippoldt Darin Chief Legal Officer
Sold, plan not stated 3×
$397.67K 3,407 at 116.72
9.6%
8 Feb 2021
Lloyd-Smith Malcolm Chief Regulatory Officer
Sold, plan not stated 3×
$380.93K 3,261 at 116.81
9.7%
8 Feb 2021
ABERNETHY MATT Chief Financial Officer
Sold, plan not stated 2×
$339.94K 2,910 at 116.82
18.2%
8 Feb 2021
Grigoriadis Dimitri E. Chief Research Officer
Sold, plan not stated 3×
$316.00K 2,708 at 116.69
3.1%
8 Feb 2021
ROBERTS EIRY Chief Medical Officer
Sold, plan not stated 2×
$275.94K 2,363 at 116.78
12.1%
8 Feb 2021
Cooke Julie Chief Human Resources Officer
Sold, plan not stated 2×
$156.19K 1,338 at 116.73
9.4%
5 Feb 2021
Gano Kyle Chief Business Development Off
Sold, plan not stated 2×
$305.18K 2,677 at 114.00
2.6%
5 Feb 2021
GORMAN KEVIN CHARLES Chief Executive Officer
Sold, plan not stated
$276.50K 2,422 at 114.16
0.5%
Showing 251–300 of 545. ← Newer Page 6 of 11 Older →